Positive opinion for Gilead’s Hepcludex
The therapy treats adults with chronic hepatitis delta virus and compensated liver disease
Read More
Tag: Hepcludex
Positive opinion for Gilead’s Hepcludex
The vital recommendation ensures marketing authorisation for treating the hepatitis delta virus
Read More
New vaccine for Ebola among CHMP recommendations
The vaccine could be Janssen’s first to win EU approval
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
